3.83
price up icon10.37%   0.36
pre-market  プレマーケット:  4.58   0.75   +19.58%
loading
前日終値:
$3.47
開ける:
$3.66
24時間の取引高:
1.25M
Relative Volume:
4.87
時価総額:
$78.58M
収益:
-
当期純損益:
$-102.09M
株価収益率:
-3.6476
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
+17.85%
1か月 パフォーマンス:
+9.68%
6か月 パフォーマンス:
-1.92%
1年 パフォーマンス:
-58.82%
1日の値動き範囲:
Value
$3.4001
$3.90
1週間の範囲:
Value
$3.3034
$3.90
52週間の値動き範囲:
Value
$2.2045
$9.486

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1233)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
108
Name
次回の収益日
2024-07-29
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

DBVT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DBVT
Dbv Technologies Adr
3.83 78.58M 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.11 106.13B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
733.59 80.61B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
649.26 38.82B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
240.55 31.03B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.15 29.28B 3.30B -501.07M 1.03B -2.1146

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
Jan 09, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Jan 09, 2025
pulisher
Jan 09, 2025

DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

DBV Technologies Reports Positive Phase 3 Study Results - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

DBV Technologies announces three-year results from EPITOPE trial - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study - The Manila Times

Jan 08, 2025
pulisher
Jan 04, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week - MSN

Jan 04, 2025
pulisher
Jan 01, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

DBV Technologies (NASDAQ:DBVT) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN

Dec 31, 2024
pulisher
Dec 29, 2024

European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN

Dec 29, 2024
pulisher
Dec 29, 2024

European Equities Traded in the US as American Depositary Rise in Thursday Trading - MSN

Dec 29, 2024
pulisher
Dec 28, 2024

European Equities Traded in the US as American Depositary Edge Lower in Thursday Trading - MSN

Dec 28, 2024
pulisher
Dec 28, 2024

European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN

Dec 28, 2024
pulisher
Dec 28, 2024

European Equities Traded in the US as American Depositary Edge Higher in Thursday Trading - MSN

Dec 28, 2024
pulisher
Dec 24, 2024

DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World

Dec 24, 2024
pulisher
Dec 21, 2024

Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN

Dec 21, 2024
pulisher
Dec 20, 2024

Oil Stocks Lead European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading - MSN

Dec 20, 2024
pulisher
Dec 18, 2024

DBV Technologies enhances severance terms for top executives - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading - MSN

Dec 18, 2024
pulisher
Dec 16, 2024

DBV Technologies' SWOT analysis: viaskin peanut stock shows promise amid challenges - Investing.com

Dec 16, 2024
pulisher
Dec 13, 2024

European Equities Traded in the US as American Depositary Lower in Tuesday Trading - MSN

Dec 13, 2024
pulisher
Dec 13, 2024

Financial Survey: Apogee Therapeutics (NASDAQ:APGE) versus DBV Technologies (NASDAQ:DBVT) - Defense World

Dec 13, 2024
pulisher
Dec 12, 2024

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows - Benzinga

Dec 12, 2024
pulisher
Dec 12, 2024

DBV Technologies jumps on US FDA approval of peanut allergy treatment - XM

Dec 12, 2024
pulisher
Dec 11, 2024

DBV Confirms Alignment with U.S. FDA on Accelerated - GlobeNewswire

Dec 11, 2024
pulisher
Dec 11, 2024

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 13 Years-Old - The Manila Times

Dec 11, 2024
pulisher
Dec 11, 2024

DBV Technologies Secures FDA Fast-Track for Revolutionary Peanut Allergy Patch in Toddlers - StockTitan

Dec 11, 2024
pulisher
Dec 11, 2024

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old - Yahoo Finance

Dec 11, 2024
pulisher
Dec 09, 2024

European Equities Traded in the US as American Depositary Tread Water in Friday Trading - MSN

Dec 09, 2024
pulisher
Dec 07, 2024

European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN

Dec 07, 2024
pulisher
Dec 04, 2024

DBV Technologies' SWOT analysis: peanut allergy treatment stock faces funding hurdles - Investing.com

Dec 04, 2024
pulisher
Dec 03, 2024

DBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.3% in November - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

DBV technologies S.A. (ADR) Revenue Breakdown – SWB:DBV1 - TradingView

Dec 02, 2024
pulisher
Dec 01, 2024

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading - MSN

Dec 01, 2024
pulisher
Nov 27, 2024

European Equities Traded in the US as American Depositary Decline in Tuesday Trading - MSN

Nov 27, 2024
pulisher
Nov 25, 2024

Dbv technologies chief medical officer sells shares worth $1,269 - Investing.com

Nov 25, 2024
pulisher
Nov 24, 2024

European Equities Traded in the US as American Depositary Rise Thursday - MSN

Nov 24, 2024
pulisher
Nov 21, 2024

DBV Technologies (STU:DBV0) Shares Outstanding (EOP) : 96.20 Mil (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

DBV Technologies (STU:DBV0) Financial Strength : 7 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

DBV Technologies (STU:DBV0) 3-Year EBITDA Growth Rate : 29.70% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Dbv Technologies Adr (DBVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Mohideen Pharis
Chief Medical Officer
Nov 22 '24
Sale
0.53
342
181
111,675
Mohideen Pharis
Chief Medical Officer
Nov 21 '24
Sale
0.54
2,350
1,269
112,017
Mohideen Pharis
Chief Medical Officer
Jul 29 '24
Sale
0.98
1,785
1,749
79,367
Mohideen Pharis
Chief Medical Officer
May 24 '24
Sale
1.36
660
898
81,152
Mohideen Pharis
Chief Medical Officer
May 22 '24
Sale
1.38
382
527
81,812
Tasse Daniel
CHIEF EXECUTIVE OFFICER
Mar 08 '24
Buy
0.83
17,094
14,188
17,094
Ndu Adora
Director
Feb 06 '24
Buy
0.89
1,825
1,624
1,825
$73.13
price down icon 0.08%
$22.19
price up icon 0.05%
$366.61
price up icon 1.18%
$43.17
price down icon 9.17%
biotechnology ONC
$177.88
price up icon 1.59%
$122.15
price down icon 3.73%
大文字化:     |  ボリューム (24 時間):